Schultheis, Michael; Staubach, Petra; Nikolakis, Georgios et al.
A centre-based ambulatory care concept for hidradenitis suppurativa improves disease activity, disease burden and patient satisfaction: results from the randomized controlled EsmAiL trialBRITISH JOURNAL OF DERMATOLOGY. 2023
Zuberbier, Torsten; Abdul Latiff, Amir; Aggelidis, Xenofon et al.
A concept for integrated care pathways for atopic dermatitis-A GA<SUP>2</SUP>LEN ADCARE initiativeCLINICAL AND TRANSLATIONAL ALLERGY. Bd. 13. H. 9. 2023
Zuberbier, Torsten; Abdul Latiff, Amir; Aggelidis, Xenofon et al.
A concept for integrated care pathways for atopic dermatitis-A GA<SUP>2</SUP>LEN ADCARE initiativeCLINICAL AND TRANSLATIONAL ALLERGY. Bd. 13. H. 9. 2023
Martinez-Negro, Maria; Oberlaender, Jennifer; Simon, Johanna et al.
A new methodology combining QCM-D and proteomic profiling enables characterization of protein adsorption on 2D surfacesJOURNAL OF COLLOID AND INTERFACE SCIENCE. Bd. 630. 2023 S. 965-972
Dummer, Reinhard; Flaherty, Keith T.; Robert, Caroline et al.
A plain language summary of the 5-year update from part 1 of the COLUMBUS study: encorafenib and binimetinib for people with BRAF V600-mutant melanomaFUTURE ONCOLOGY. Bd. 19. H. 16. 2023 S. 1091-1098
Kommoss, Katharina S.; Bieler, Tabea; Ringen, Julia et al.
A simple tool for evaluation of inflammation in psoriasis: Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio as markers in psoriasis patients and related murine models of psoriasis-like skin diseaseJOURNAL OF MOLECULAR MEDICINE-JMM. 2023
Wang, Shunfeng; Neufurth, Meik; Schepler, Hadrian et al.
Acceleration of Wound Healing through Amorphous Calcium Carbonate, Stabilized with High-Energy PolyphosphatePHARMACEUTICS. Bd. 15. H. 2. 2023
Majenka, Pawel; Loquai, Carmen; Schoening, Tilman et al.
Acute low back pain as infusion-related reaction to monoclonal antibodiesFRONTIERS IN ONCOLOGY. Bd. 13. 2023
Kirkwood, John; Del Vecchio, Michele; Weber, Jeffrey et al.
Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trialNATURE MEDICINE. 2023
Kirkwood, John M.; Del Vecchio, Michele; Weber, Jeffrey et al.
Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial (16 OCT, 10.1038/s41591-023-02583-2, 2023 )NATURE MEDICINE. 2023